{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T14:20:17Z","timestamp":1784816417794,"version":"3.55.0"},"reference-count":53,"publisher":"Public Library of Science (PLoS)","issue":"12","license":[{"start":{"date-parts":[[2024,12,19]],"date-time":"2024-12-19T00:00:00Z","timestamp":1734566400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100007446","name":"King Khalid University","doi-asserted-by":"publisher","award":["RGP .2 \/244\/45"],"award-info":[{"award-number":["RGP .2 \/244\/45"]}],"id":[{"id":"10.13039\/501100007446","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100019286","name":"Ajman University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100019286","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"abstract":"<jats:p>Alzheimer\u2019s disease (AD) is characterized by the aggregation of amyloid \u03b2 (A\u03b2) peptides and the formation of plaques in the brain, primarily derived from the proteolytic degradation of amyloid precursor protein (APP). Cathepsin B (CatB) is a cysteine protease that plays a pivotal role in this process, making it a potential target for the development of anti-Alzheimer\u2019s therapies. Apart from AD, CatB is implicated in various physiological and pathological processes, including cancer. Given the critical role of CatB in these diseases, identifying effective inhibitors is of significant therapeutic interest. In this study, we employed a systematic virtual screening approach using repurposed molecules from the DrugBank database to identify potential CatB inhibitors. Primarily, we focused on binding affinities and selectivity to pinpoint potential hits against CatB. Two repurposed molecules, Lurasidone and Paliperidone, emerged as promising candidates with significant affinity for CatB. These molecules demonstrated favorable drug profiles and exhibited preferential binding to the catalytic pocket of CatB via interacting with functionally significant residues. To further explore the binding mechanism and stability of the CatB-drug complexes, molecular dynamics (MD) simulations were conducted for 500 ns. The results revealed that CatB and Lurasidone, as well as Paliperidone, form stable complexes throughout the simulation. Taken together, the findings suggest that Lurasidone and Paliperidone can act as repurposed CatB inhibitors with potential applications in the development of therapeutics against AD and other CatB-associated diseases after further validation.<\/jats:p>","DOI":"10.1371\/journal.pone.0316010","type":"journal-article","created":{"date-parts":[[2024,12,19]],"date-time":"2024-12-19T18:37:21Z","timestamp":1734633441000},"page":"e0316010","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":5,"title":["Unveiling Cathepsin B inhibition with repurposed drugs for anticancer and anti-Alzheimer\u2019s drug discovery"],"prefix":"10.1371","volume":"19","author":[{"given":"Mohammed","family":"Alrouji","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5077-9380","authenticated-orcid":true,"given":"Sabina","family":"Yasmin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammed S.","family":"Alshammari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0151-8309","authenticated-orcid":true,"given":"Fahad A.","family":"Alhumaydhi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0679-6586","authenticated-orcid":true,"given":"Sharaf E.","family":"Sharaf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moyad","family":"Shahwan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7055-7056","authenticated-orcid":true,"given":"Anas","family":"Shamsi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2024,12,19]]},"reference":[{"key":"pone.0316010.ref001","doi-asserted-by":"crossref","first-page":"425","DOI":"10.12688\/f1000research.50786.1","article-title":"Epidemiology of Alzheimer\u2019s disease and other dementias: Rising global burden and forecasted trends.","volume":"10","author":"SF Javaid","year":"2021","journal-title":"F1000Research."},{"issue":"10274","key":"pone.0316010.ref002","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1016\/S0140-6736(21)00364-0","article-title":"New global initiative to tackle Alzheimer\u2019s disease","volume":"397","author":"N. Siva","year":"2021","journal-title":"The Lancet"},{"issue":"10","key":"pone.0316010.ref003","doi-asserted-by":"crossref","first-page":"5481","DOI":"10.1038\/s41380-021-01249-0","article-title":"The amyloid-\u03b2 pathway in Alzheimer\u2019s disease","volume":"26","author":"H Hampel","year":"2021","journal-title":"Molecular psychiatry"},{"issue":"19","key":"pone.0316010.ref004","doi-asserted-by":"crossref","first-page":"14794","DOI":"10.3390\/ijms241914794","article-title":"Amyloid Precursor Protein and Alzheimer\u2019s Disease","volume":"24","author":"KS Orobets","year":"2023","journal-title":"International Journal of Molecular Sciences"},{"key":"pone.0316010.ref005","doi-asserted-by":"crossref","first-page":"113320","DOI":"10.1016\/j.ejmech.2021.113320","article-title":"Alzheimer\u2019s disease and its treatment by different approaches: A review","volume":"216","author":"S Srivastava","year":"2021","journal-title":"European Journal of Medicinal Chemistry"},{"key":"pone.0316010.ref006","doi-asserted-by":"crossref","first-page":"118020","DOI":"10.1016\/j.lfs.2020.118020","article-title":"The role of CREB and BDNF in neurobiology and treatment of Alzheimer\u2019s disease","volume":"257","author":"M Amidfar","year":"2020","journal-title":"Life sciences"},{"issue":"6555","key":"pone.0316010.ref007","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1126\/science.abi6401","article-title":"Treatments for Alzheimer\u2019s disease emerge","volume":"373","author":"DJ Selkoe","year":"2021","journal-title":"Science"},{"issue":"8","key":"pone.0316010.ref008","doi-asserted-by":"crossref","first-page":"140428","DOI":"10.1016\/j.bbapap.2020.140428","article-title":"Cathepsin B in neurodegeneration of Alzheimer\u2019s disease, traumatic brain injury, and related brain disorders.","volume":"1868","author":"V Hook","year":"2020","journal-title":"Biochimica et Biophysica Acta (BBA)-Proteins and Proteomics."},{"issue":"8","key":"pone.0316010.ref009","doi-asserted-by":"crossref","first-page":"1946","DOI":"10.3390\/cells10081946","article-title":"Identification of novel cathepsin B inhibitors with implications in Alzheimer\u2019s disease: Computational refining and biochemical evaluation.","volume":"10","author":"N Chitranshi","year":"2021","journal-title":"Cells."},{"issue":"6","key":"pone.0316010.ref010","doi-asserted-by":"crossref","first-page":"1944","DOI":"10.3390\/ijms21061944","article-title":"Regulation of the proteolytic activity of cysteine cathepsins by oxidants","volume":"21","author":"G Lalmanach","year":"2020","journal-title":"International journal of molecular sciences"},{"issue":"26","key":"pone.0316010.ref011","doi-asserted-by":"crossref","first-page":"4524","DOI":"10.1021\/jm010206q","article-title":"Identification of dipeptidyl nitriles as potent and selective inhibitors of cathepsin B through structure-based drug design","volume":"44","author":"PD Greenspan","year":"2001","journal-title":"Journal of medicinal chemistry"},{"issue":"41","key":"pone.0316010.ref012","doi-asserted-by":"crossref","first-page":"19593","DOI":"10.1039\/D2NJ03037C","article-title":"Cathepsin B as a target in cancer therapy and imaging","volume":"46","author":"Y Shen","year":"2022","journal-title":"New Journal of Chemistry"},{"issue":"12","key":"pone.0316010.ref013","doi-asserted-by":"crossref","first-page":"2344","DOI":"10.7150\/jca.86531","article-title":"The role of Cathepsin B in pathophysiologies of non-tumor and tumor tissues: a systematic review","volume":"14","author":"J Wang","year":"2023","journal-title":"Journal of Cancer"},{"issue":"1","key":"pone.0316010.ref014","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1016\/j.sjbs.2021.09.014","article-title":"Exploring the role of cathepsin in rheumatoid arthritis","volume":"29","author":"T Behl","year":"2022","journal-title":"Saudi Journal of Biological Sciences"},{"issue":"1","key":"pone.0316010.ref015","doi-asserted-by":"crossref","first-page":"25","DOI":"10.4103\/1673-5374.264444","article-title":"Microglial cathepsin B as a key driver of inflammatory brain diseases and brain aging","volume":"15","author":"H. Nakanishi","year":"2020","journal-title":"Neural regeneration research"},{"key":"pone.0316010.ref016","volume-title":"Biochem Soc Symp","author":"I Podgorski","year":"2003"},{"issue":"3","key":"pone.0316010.ref017","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1517\/14728222.2013.740461","article-title":"Cathepsin B as a cancer target","volume":"17","author":"CS Gondi","year":"2013","journal-title":"Expert opinion on therapeutic targets"},{"issue":"1","key":"pone.0316010.ref018","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.tips.2007.10.011","article-title":"Cysteine cathepsin proteases as pharmacological targets in cancer","volume":"29","author":"C Palermo","year":"2008","journal-title":"Trends in pharmacological sciences"},{"issue":"10","key":"pone.0316010.ref019","doi-asserted-by":"crossref","first-page":"2076","DOI":"10.1016\/j.drudis.2019.06.014","article-title":"Drug repurposing: a promising tool to accelerate the drug discovery process","volume":"24","author":"V Parvathaneni","year":"2019","journal-title":"Drug Discovery Today"},{"issue":"2","key":"pone.0316010.ref020","doi-asserted-by":"crossref","first-page":"59","DOI":"10.12793\/tcp.2019.27.2.59","article-title":"A review of computational drug repurposing","volume":"27","author":"K. Park","year":"2019","journal-title":"Translational and clinical pharmacology"},{"issue":"1","key":"pone.0316010.ref021","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1038\/nrd.2018.168","article-title":"Drug repurposing: progress, challenges and recommendations.","volume":"18","author":"S Pushpakom","year":"2019","journal-title":"Nature reviews Drug discovery."},{"key":"pone.0316010.ref022","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/j.lfs.2018.06.025","article-title":"Novel multi-target directed ligand-based strategies for reducing neuroinflammation in Alzheimer\u2019s disease","volume":"207","author":"TJ Wenzel","year":"2018","journal-title":"Life sciences"},{"issue":"9","key":"pone.0316010.ref023","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1016\/S0968-0896(97)00105-3","article-title":"E-64 analogues as inhibitors of cathepsin B. On the role of the absolute configuration of the epoxysuccinyl group","volume":"5","author":"N Schaschke","year":"1997","journal-title":"Bioorg Med Chem"},{"issue":"7","key":"pone.0316010.ref024","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1016\/j.bmcl.2018.02.042","article-title":"Cathepsin B inhibitors: Further exploration of the nitroxoline core","volume":"28","author":"I Sosi\u010d","year":"2018","journal-title":"Bioorg Med Chem Lett"},{"issue":"92037","key":"pone.0316010.ref025","first-page":"1000","article-title":"Using AutoDock 4 and AutoDock vina with AutoDockTools: a tutorial.","volume":"10550","author":"R Huey","year":"2012","journal-title":"The Scripps Research Institute Molecular Graphics Laboratory."},{"issue":"1","key":"pone.0316010.ref026","first-page":"82","volume":"40","author":"WL DeLano","year":"2002","journal-title":"CCP4 Newsl Protein Crystallogr"},{"issue":"4","key":"pone.0316010.ref027","doi-asserted-by":"crossref","DOI":"10.1093\/bib\/bbaa279","article-title":"InstaDock: A single-click graphical user interface for molecular docking-based virtual high-throughput screening","volume":"22","author":"T Mohammad","year":"2021","journal-title":"Briefings in Bioinformatics"},{"key":"pone.0316010.ref028","volume-title":"Discovery Studio Visualizer. 2.","author":"D. Visualizer","year":"2005"},{"issue":"D1","key":"pone.0316010.ref029","doi-asserted-by":"crossref","first-page":"D506","DOI":"10.1093\/nar\/gky1049","article-title":"UniProt: a worldwide hub of protein knowledge","volume":"47","author":"U. Consortium","year":"2019","journal-title":"Nucleic acids research"},{"issue":"D1","key":"pone.0316010.ref030","doi-asserted-by":"crossref","first-page":"D1265","DOI":"10.1093\/nar\/gkad976","article-title":"DrugBank 6.0: the DrugBank Knowledgebase for 2024","volume":"52","author":"C Knox","year":"2024","journal-title":"Nucleic Acids Research"},{"key":"pone.0316010.ref031","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1007\/s10593-014-1496-1","article-title":"Prediction of the biological activity spectra of organic compounds using the PASS online web resource","volume":"50","author":"D Filimonov","year":"2014","journal-title":"Chemistry of Heterocyclic Compounds"},{"key":"pone.0316010.ref032","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1038\/newbio233223b0","article-title":"Protein data bank","volume":"233","author":"PD Bank","year":"1971","journal-title":"Nature New Biol"},{"issue":"4","key":"pone.0316010.ref033","doi-asserted-by":"crossref","first-page":"823","DOI":"10.3390\/molecules25040823","article-title":"Virtual screening approach to identify high-affinity inhibitors of serum and glucocorticoid-regulated kinase 1 among bioactive natural products: Combined molecular docking and simulation studies.","volume":"25","author":"T Mohammad","year":"2020","journal-title":"Molecules."},{"key":"pone.0316010.ref034","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1007\/978-981-15-6815-2_7","article-title":"Molecular dynamics simulation of protein and protein\u2013ligand complexes.","author":"R Shukla","year":"2020","journal-title":"Computer-aided drug design."},{"issue":"20","key":"pone.0316010.ref035","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.2174\/1568026618666181025114157","article-title":"Advancements in docking and molecular dynamics simulations towards ligand-receptor interactions and structure-function relationships","volume":"18","author":"AA Naqvi","year":"2018","journal-title":"Current topics in medicinal chemistry"},{"issue":"16","key":"pone.0316010.ref036","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1002\/jcc.20291","article-title":"GROMACS: fast, flexible, and free","volume":"26","author":"D Van Der Spoel","year":"2005","journal-title":"Journal of computational chemistry"},{"issue":"25","key":"pone.0316010.ref037","doi-asserted-by":"crossref","first-page":"2135","DOI":"10.1002\/jcc.23354","article-title":"CHARMM36 all\u2010atom additive protein force field: Validation based on comparison to NMR data","volume":"34","author":"J Huang","year":"2013","journal-title":"Journal of computational chemistry"},{"key":"pone.0316010.ref038","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1007\/BF00355047","article-title":"PRODRG, a program for generating molecular topologies and unique molecular descriptors from coordinates of small molecules","volume":"10","author":"DM Van Aalten","year":"1996","journal-title":"Journal of computer-aided molecular design"},{"issue":"43","key":"pone.0316010.ref039","doi-asserted-by":"crossref","first-page":"9954","DOI":"10.1021\/jp003020w","article-title":"Structure and dynamics of the TIP3P, SPC, and SPC\/E water models at 298 K","volume":"105","author":"P Mark","year":"2001","journal-title":"The Journal of Physical Chemistry A"},{"issue":"8","key":"pone.0316010.ref040","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1016\/j.jmgm.2009.01.006","article-title":"Free-energy landscape, principal component analysis, and structural clustering to identify representative conformations from molecular dynamics simulations: The myoglobin case","volume":"27","author":"E Papaleo","year":"2009","journal-title":"Journal of molecular graphics and modelling"},{"issue":"3","key":"pone.0316010.ref041","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1504\/IJAPR.2016.079733","article-title":"Principal component analysis-a tutorial","volume":"3","author":"A. Tharwat","year":"2016","journal-title":"International Journal of Applied Pattern Recognition"},{"issue":"5","key":"pone.0316010.ref042","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1517\/17460441.2015.1032936","article-title":"The MM\/PBSA and MM\/GBSA methods to estimate ligand-binding affinities.","volume":"10","author":"S Genheden","year":"2015","journal-title":"Expert opinion on drug discovery."},{"issue":"10","key":"pone.0316010.ref043","doi-asserted-by":"crossref","first-page":"6281","DOI":"10.1021\/acs.jctc.1c00645","article-title":"gmx_MMPBSA: a new tool to perform end-state free energy calculations with GROMACS","volume":"17","author":"MS Vald\u00e9s-Tresanco","year":"2021","journal-title":"Journal of chemical theory and computation"},{"key":"pone.0316010.ref044","first-page":"99","author":"A Sellami","year":"2021"},{"key":"pone.0316010.ref045","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.neulet.2013.05.056","article-title":"CA-074Me, a cathepsin B inhibitor, decreases APP accumulation and protects primary rat cortical neurons treated with okadaic acid","volume":"548","author":"K Cho","year":"2013","journal-title":"Neuroscience letters"},{"issue":"14","key":"pone.0316010.ref046","doi-asserted-by":"crossref","first-page":"4791","DOI":"10.1021\/bi00014a037","article-title":"Crystal structure of cathepsin B inhibited with CA030 at 2.0-. ANG. resolution: A basis for the design of specific epoxysuccinyl inhibitors","volume":"34","author":"D Turk","year":"1995","journal-title":"Biochemistry"},{"key":"pone.0316010.ref047","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1007\/s10822-016-0005-2","article-title":"Exploring the stability of ligand binding modes to proteins by molecular dynamics simulations","volume":"31","author":"K Liu","year":"2017","journal-title":"Journal of computer-aided molecular design"},{"issue":"2","key":"pone.0316010.ref048","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1006\/jmbi.1994.1017","article-title":"Significance of root-mean-square deviation in comparing three-dimensional structures of globular proteins","volume":"235","author":"VN Maiorov","year":"1994","journal-title":"Journal of molecular biology"},{"key":"pone.0316010.ref049","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1134\/S0026893308040195","article-title":"Radius of gyration as an indicator of protein structure compactness","volume":"42","author":"MY Lobanov","year":"2008","journal-title":"Molecular Biology"},{"key":"pone.0316010.ref050","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1007\/s00894-009-0454-9","article-title":"Solvent accessible surface area approximations for rapid and accurate protein structure prediction","volume":"15","author":"E Durham","year":"2009","journal-title":"Journal of molecular modeling"},{"issue":"5","key":"pone.0316010.ref051","doi-asserted-by":"crossref","first-page":"456","DOI":"10.2174\/1389203715666140327114232","article-title":"A review of methods available to estimate solvent-accessible surface areas of soluble proteins in the folded and unfolded states","volume":"15","author":"S Ausaf Ali","year":"2014","journal-title":"Current Protein and Peptide Science"},{"key":"pone.0316010.ref052","volume-title":"Hydrogen bonds in proteins: role and strength. eLS","author":"RE Hubbard","year":"2010"},{"key":"pone.0316010.ref053","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1007\/978-1-4939-9752-7_7","article-title":"Hydrogen bonds in protein-ligand complexes.","author":"G Bitencourt-Ferreira","year":"2019","journal-title":"Docking screens for drug discovery"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0316010","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,19]],"date-time":"2024-12-19T18:37:36Z","timestamp":1734633456000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0316010"}},"subtitle":[],"editor":[{"given":"Ahmed A.","family":"Al-Karmalawy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2024,12,19]]},"references-count":53,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2024,12,19]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0316010","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12,19]]}}}